4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide

C100H134F2N28O10S5 — CID 163772151

IUPAC4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide
SMILESCNS(=O)(=O)c1ccc(CC2CCC(C)(F)CC2)c(-c2nnn(C)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCC(C)(F)C2)c(-c2nnn(C)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCCC2)c(-c2nnn(C3CC3)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCCC2)c(-c2nnn(C3CCN(c4cccnc4)C3)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCCC2)c(-c2nnn(C3CN(c4ccccc4)C3)n2)c1
InChIInChI=1S/C24H31N7O2S.C24H30N6O2S.C18H25N5O2S.2C17H24FN5O2S/c1-25-34(32,33)22-10-9-19(14-18-6-3-2-4-7-18)23(15-22)24-27-29-31(28-24)21-11-13-30(17-21)20-8-5-12-26-16-20;1-25-33(31,32)22-13-12-19(14-18-8-4-2-5-9-18)23(15-22)24-26-28-30(27-24)21-16-29(17-21)20-10-6-3-7-11-20;1-19-26(24,25)16-10-7-14(11-13-5-3-2-4-6-13)17(12-16)18-20-22-23(21-18)15-8-9-15;1-17(18)8-6-12(7-9-17)10-13-4-5-14(26(24,25)19-2)11-15(13)16-20-22-23(3)21-16;1-17(18)8-4-5-12(11-17)9-13-6-7-14(26(24,25)19-2)10-15(13)16-20-22-23(3)21-16/h5,8-10,12,15-16,18,21,25H,2-4,6-7,11,13-14,17H2,1H3;3,6-7,10-13,15,18,21,25H,2,4-5,8-9,14,16-17H2,1H3;7,10,12-13,15,19H,2-6,8-9,11H2,1H3;4-5,11-12,19H,6-10H2,1-3H3;6-7,10,12,19H,4-5,8-9,11H2,1-3H3
InChIKeyMHIVZPLYIHDZDE-UHFFFAOYSA-N
MW2086.69 g/mol
LogP13.85
Rot. Bonds30

About 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide

4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide (PubChem CID 163772151) has the molecular formula C100H134F2N28O10S5 and a molecular weight of 2086.69 g/mol. Its IUPAC name is 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide.

Molecular Properties

Compound Name4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide
PubChem CID163772151
Molecular FormulaC100H134F2N28O10S5
Molecular Weight2086.69 g/mol
Exact Mass2084.94
IUPAC Name4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide
SMILESCNS(=O)(=O)c1ccc(CC2CCC(C)(F)CC2)c(-c2nnn(C)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCC(C)(F)C2)c(-c2nnn(C)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCCC2)c(-c2nnn(C3CC3)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCCC2)c(-c2nnn(C3CCN(c4cccnc4)C3)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCCC2)c(-c2nnn(C3CN(c4ccccc4)C3)n2)c1
InChIInChI=1S/C24H31N7O2S.C24H30N6O2S.C18H25N5O2S.2C17H24FN5O2S/c1-25-34(32,33)22-10-9-19(14-18-6-3-2-4-7-18)23(15-22)24-27-29-31(28-24)21-11-13-30(17-21)20-8-5-12-26-16-20;1-25-33(31,32)22-13-12-19(14-18-8-4-2-5-9-18)23(15-22)24-26-28-30(27-24)21-16-29(17-21)20-10-6-3-7-11-20;1-19-26(24,25)16-10-7-14(11-13-5-3-2-4-6-13)17(12-16)18-20-22-23(21-18)15-8-9-15;1-17(18)8-6-12(7-9-17)10-13-4-5-14(26(24,25)19-2)11-15(13)16-20-22-23(3)21-16;1-17(18)8-4-5-12(11-17)9-13-6-7-14(26(24,25)19-2)10-15(13)16-20-22-23(3)21-16/h5,8-10,12,15-16,18,21,25H,2-4,6-7,11,13-14,17H2,1H3;3,6-7,10-13,15,18,21,25H,2,4-5,8-9,14,16-17H2,1H3;7,10,12-13,15,19H,2-6,8-9,11H2,1H3;4-5,11-12,19H,6-10H2,1-3H3;6-7,10,12,19H,4-5,8-9,11H2,1-3H3
InChIKeyMHIVZPLYIHDZDE-UHFFFAOYSA-N
XLogP13.85
TPSA468.22 Ų
H-Bond Donors5
H-Bond Acceptors33
Rotatable Bonds30
Heavy Atoms145
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002086.69
LogP ≤ 513.85
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1033

Analyze 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide
CID 163422069
4-(cyclohexylmethyl)-3-(1-cyclopropylimidazol-4-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[(2,5-difluorophenyl)methyl]-N-methyl-3-(1-methyltetrazol-5-yl)benzenesulfonamide;4-[(2,5-difluorophenyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(3-fluoro-5-methylphenyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide
CID 163455167
4-(cyclohexylmethyl)-N-methyl-3-[2-(1-methylsulfonylpiperidin-4-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-(2-piperidin-4-yltetrazol-5-yl)benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-prop-1-en-2-ylpiperidin-4-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpiperidin-4-yl)tetrazol-5-yl]benzenesulfonamide
CID 163579095
tert-butyl 4-[5-[2-(cyclohexylmethyl)-5-(methylsulfamoyl)phenyl]tetrazol-2-yl]piperidine-1-carboxylate;4-(cyclohexylmethyl)-N-methyl-3-[2-(2-methylpropyl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-(2-propan-2-yltetrazol-5-yl)benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(pyridin-3-ylmethyl)tetrazol-5-yl]benzenesulfonamide
CID 163630238
4-(cyclohexylmethyl)-3-[2-(2-hydroxyethyl)tetrazol-5-yl]-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-methylsulfonylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-prop-1-en-2-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-(2-pyridin-3-yltetrazol-5-yl)benzenesulfonamide
CID 163685676

Frequently Asked Questions

What is the IUPAC name of 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide?
The IUPAC name of 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide (CID 163772151) is 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide.
What is the SMILES notation for 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide?
The canonical SMILES for 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide is CNS(=O)(=O)c1ccc(CC2CCC(C)(F)CC2)c(-c2nnn(C)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCC(C)(F)C2)c(-c2nnn(C)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCCC2)c(-c2nnn(C3CC3)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCCC2)c(-c2nnn(C3CCN(c4cccnc4)C3)n2)c1.CNS(=O)(=O)c1ccc(CC2CCCCC2)c(-c2nnn(C3CN(c4ccccc4)C3)n2)c1.
What is the InChIKey of 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide?
The InChIKey is MHIVZPLYIHDZDE-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H31N7O2S.C24H30N6O2S.C18H25N5O2S.2C17H24FN5O2S/c1-25-34(32,33)22-10-9-19(14-18-6-3-2-4-7-18)23(15-22)24-27-29-31(28-24)21-11-13-30(17-21)20-8-5-12-26-16-20;1-25-33(31,32)22-13-12-19(14-18-8-4-2-5-9-18)23(15-22)24-26-28-30(27-24)21-16-29(17-21)20-10-6-3-7-11-20;1-19-26(24,25)16-10-7-14(11-13-5-3-2-4-6-13)17(12-16)18-20-22-23(21-18)15-8-9-15;1-17(18)8-6-12(7-9-17)10-13-4-5-14(26(24,25)19-2)11-15(13)16-20-22-23(3)21-16;1-17(18)8-4-5-12(11-17)9-13-6-7-14(26(24,25)19-2)10-15(13)16-20-22-23(3)21-16/h5,8-10,12,15-16,18,21,25H,2-4,6-7,11,13-14,17H2,1H3;3,6-7,10-13,15,18,21,25H,2,4-5,8-9,14,16-17H2,1H3;7,10,12-13,15,19H,2-6,8-9,11H2,1H3;4-5,11-12,19H,6-10H2,1-3H3;6-7,10,12,19H,4-5,8-9,11H2,1-3H3.
What are the key properties of 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide?
4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide has a molecular weight of 2086.69 g/mol, XLogP of 13.85, 30 rotatable bonds, 5 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(cyclohexylmethyl)-3-(2-cyclopropyltetrazol-5-yl)-N-methylbenzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-phenylazetidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-(cyclohexylmethyl)-N-methyl-3-[2-(1-pyridin-3-ylpyrrolidin-3-yl)tetrazol-5-yl]benzenesulfonamide;4-[(3-fluoro-3-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(4-fluoro-4-methylcyclohexyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide is sourced from PubChem (CID 163772151), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).